Press "Enter" to skip to content

New patent for Sun Pharm drug WINLEVI

0
Copyright © DrugPatentWatch. Originally published at New patent for Sun Pharm drug WINLEVI

Annual Drug Patent Expirations for WINLEVI
Annual Drug Patent Expirations for WINLEVI

Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has seventy patent family members in twenty-six countries.

The generic ingredient in WINLEVI is clascoterone. One supplier is listed for this compound. Additional details are available on the clascoterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Sun Pharm drug WINLEVI
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions